Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.80 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.68 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.68 |
| ▸ | CNR1 | P21554 | 4/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.66 |
| ▸ | HPGD | P15428 | 2/20 | 0.66 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.66 |
| ▸ | MEN1 | O00255 | 1/20 | 0.66 |
| ▸ | MAPT | P10636 | 1/20 | 0.66 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.66 |
| ▸ | BLM | P54132 | 1/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL30468934 | 1.00 | DNM1 (0.80) | DNM1SLC6A5EPHX2CNR1ALDH1A1 | |
| SCHEMBL6127761 | 0.99 | DNM1 (0.82) | DNM1SLC6A5EPHX2CNR1ALDH1A1 | |
| SCHEMBL6417641 | 0.99 | DNM1 (0.82) | DNM1SLC6A5EPHX2CNR1ALDH1A1 | |
| SCHEMBL4622859 | 0.99 | DNM1 (0.82) | DNM1SLC6A5EPHX2CNR1ALDH1A1 | |
| SCHEMBL75309 | 0.99 | DNM1 (0.82) | DNM1SLC6A5EPHX2CNR1ALDH1A1 | |
| SCHEMBL25134837 | 0.99 | DNM1 (0.82) | DNM1SLC6A5EPHX2CNR1ALDH1A1 | |
| SCHEMBL9505196 | 0.99 | DNM1 (0.82) | DNM1SLC6A5EPHX2CNR1ALDH1A1 | |
| SCHEMBL14060400 | 0.99 | DNM1 (0.82) | DNM1SLC6A5EPHX2CNR1ALDH1A1 | |
| SCHEMBL3427754 | 0.99 | DNM1 (0.82) | DNM1SLC6A5EPHX2CNR1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL28527824 | 0.96 | DNM1 (0.74) | DNM1CNR1ALDH1A1HPGDTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2325278-B1 | Polycationic viscoelastic compositions | STEPAN CO (US) | 2015-09-09 | — | — | EP | disclosed |
| US-8222455-B2 | Polycationic viscoelastic compositions | STEPAN COMPANY (US) | 2012-07-17 | — | — | US | disclosed |
| EP-1945734-B1 | POLYCATIONIC VISCOELASTIC COMPOSITIONS | STEPAN CO (US) | 2011-08-17 | — | — | EP | disclosed |
| US-20110190530-A1 | Polycationic Viscoelastic Compositions | KNOX PAUL | 2011-08-04 | — | — | US | disclosed |
| EP-2325278-A1 | Polycationic viscoelastic compositions | STEPAN COMPANY (US) | 2011-05-25 | — | — | EP | disclosed |
| US-7947633-B2 | Polycationic viscoelastic compositions | STEPAN COMPANY (US) | 2011-05-24 | — | — | US | disclosed |
| US-7884057-B2 | Quaternary ammonium compounds with two cationic sites connected through a linker; hydraulic fluids, demulsifiers, foamers, organoclays, thickeners, biocides, and oil field fluids. | STEPAN COMPANY (US) | 2011-02-08 | — | — | US | disclosed |
| US-7879769-B2 | Quaternary ammonium compounds with two cationic sites connected through a linker; hydraulic fluids, demulsifiers, foamers, organoclays, thickeners, biocides, and oil field fluids. | STEPAN COMPANY (US) | 2011-02-01 | — | — | US | disclosed |
| US-20100311622-A1 | Polycationic Viscoelastic Compositions | KNOX PAUL | 2010-12-09 | — | — | US | disclosed |
| US-7772165-B2 | Polycationic viscoelastic compositions | STEPHAN COMPANY (US) | 2010-08-10 | — | — | US | disclosed |
| EP-1945734-A4 | POLYCATIONIC VISCOELASTIC COMPOSITIONS | STEPAN CO (US) | 2008-12-03 | — | — | EP | disclosed |
| US-20080255009-A1 | Quaternary ammonium compounds with two cationic sites connected through a linker; hydraulic fluids, demulsifiers, foamers, organoclays, thickeners, biocides, and oil field fluids. | STEPAN COMPANY | 2008-10-16 | — | — | US | disclosed |
| US-20080248976-A1 | POLYCATIONIC VISCOELASTIC COMPOSITIONS | STEPAN COMPANY | 2008-10-09 | — | — | US | disclosed |
| US-20080248977-A1 | Quaternary ammonium compounds with two cationic sites connected through a linker; hydraulic fluids, demulsifiers, foamers, organoclays, thickeners, biocides, and oil field fluids. | STEPAN COMPANY | 2008-10-09 | — | — | US | disclosed |
| EP-1945734-A2 | POLYCATIONIC VISCOELASTIC COMPOSITIONS | STEPAN COMPANY (US) | 2008-07-23 | — | — | EP | disclosed |
| WO-2007056392-A9 | POLYCATIONIC VISCOELASTIC COMPOSITIONS | STEPAN CO (US) | 2007-07-05 | — | — | WO | disclosed |
| WO-2007056393-A2 | POLYCATIONIC VISCOELASTIC COMPOSITIONS | STEPAN COMPANY (US) | 2007-05-18 | — | — | WO | disclosed |
| WO-2007056284-A2 | POLYCATIONIC VISCOELASTIC COMPOSITIONS | STEPAN COMPANY (US) | 2007-05-18 | — | — | WO | disclosed |
| WO-2007056392-A2 | POLYCATIONIC VISCOELASTIC COMPOSITIONS | STEPAN COMPANY (US) | 2007-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110190530-A1 | Polycationic Viscoelastic Compositions | AQP1, PBRM1, PARG | DNM1 137/4885SLC6A5 696/4885EPHX2 4431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.